Research Article
Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients
Table 2
Univariate Cox regression analyses of cardiovascular events, cardiovascular mortality, and all-cause mortality.
| Parameter | Cardiovascular events |
Cardiovascular mortality | All-cause mortality | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| Age (year) | 1.06 (1.02–1.11) | 0.004 | 1.13 (1.04–1.26) | 0.002 | 1.09 (1.02–1.18) | 0.005 | Male gender | 1.52 (0.65–3.68) | 0.33 | 2.02 (0.53–9.57) | 0.31 | 2.01 (0.63–7.53) | 0.24 | BMI (kg/m2) | 1.11 (0.98–1.25) | 0.10 | 0.99 (0.79–1.20) | 0.93 | 1.00 (0.83–1.18) | 0.97 | Diabetes mellitus | 1.42 (0.59–3.30) | 0.42 | 1.70 (0.42–6.41) | 0.43 | 2.12 (0.66–6.77) | 0.20 | Duration of dialysis (year) | 0.95 (0.85–1.03) | 0.23 | 0.94 (0.77–1.07) | 0.40 | 0.94 (0.81–1.06) | 0.36 | Serum creatinine | 0.97 (0.83–1.12) | 0.64 | 0.95 (0.74–1.19) | 0.65 | 0.90 (0.72–1.10) | 0.30 | (per/week) | 0.23 (0.06–1.00) | 0.05 | 0.69 (0.08–7.40) | 0.75 | 0.80 (0.12–6.29) | 0.83 | nPCR (g/kg/day) | 0.05 (0.005–0.61) | 0.02 | 1.72 (0.05–62.78) | 0.77 | 1.54 (0.06–39.72) | 0.79 | Cardiothoracic ratio (%) | 1.09 (1.01–1.18) | 0.02 | 1.15 (1.02–1.29) | 0.02 | 1.09 (0.98–1.21) | 0.10 | Systolic blood pressure (mmHg) | 1.00 (0.98–1.02) | 0.93 | 1.00 (0.97–1.03) | 0.95 | 1.00 (0.98–1.03) | 0.75 | Hemoglobin (g/dL) | 0.90 (0.65–1.26) | 0.54 | 0.35 (0.01–11.63) | 0.55 | 0.95 (0.62–1.45) | 0.80 | Serum albumin (g/dL) | 0.55 (0.18–1.68) | 0.29 | 1.11 (0.19–7.42) | 0.91 | 1.14 (0.25–5.81) | 0.87 | Total cholesterol (mg/dL) | 0.99 (0.97–1.00) | 0.06 | 0.98 (0.96–1.00) | 0.10 | 0.99 (0.98–1.01) | 0.47 | Serum calcium (mg/dL) | 0.83 (0.59–1.18) | 0.30 | 0.72 (0.40–1.23) | 0.23 | 0.85 (0.52–1.34) | 0.48 | Serum phosphorus (mg/dL) | 0.83 (0.61–1.14) | 0.25 | 0.94 (0.57–1.54) | 0.80 | 0.82 (0.54–1.26) | 0.36 | Intact PTH (pg/mL) | 1.00 (0.99–1.00) | 0.91 | 1.00 (0.998–1.004) | 0.35 | 1.00 (0.997–1.003) | 0.79 | Klotho (Low) | 2.17 (0.83–5.18) | 0.11 | 3.50 (0.86–13.26) | 0.08 | 4.38 (1.37–14.04) | 0.014 | Serum FGF23 (High) | 1.33 (0.57–3.22) | 0.51 | 1.95 (0.52–9.25) | 0.33 | 0.98 (0.31–3.15) | 0.98 |
1,25(OH)2D (pg/mL) | 1.00 (0.90–1.09) | 0.96 | 1.07 (0.92–1.21) | 0.34 | 1.04 (0.90–1.17) | 0.96 | Vitamin D sterols (No) | 0.65 (0.27–1.50) | 0.31 | 0.41 (0.09–1.56) | 0.19 | 0.59 (0.17–1.84) | 0.36 | Phosphate binders (No) | 1.48 (0.24–5.09) | 0.61 | 2.01 (3.14–3.14) | 0.25 | 2.01 (2.29–2.29) | 0.19 | ESA (No) | 0.94 (0.27–1.50) | 0.93 | 1.94 (2.42–2.42) | 0.19 | 1.94 (1.76–1.76) | 0.13 | ARBs/ACEIs (No) | 1.57 (0.68–3.82) | 0.29 | 3.66 (0.88–24.60) | 0.08 | 3.15 (0.94–14.22) | 0.06 |
|
|
BMI: body mass index; nPCR: normalized protein catabolism rate; PTH: parathyroid hormone; Klotho: serum soluble Klotho; FGF23: fibroblast growth factor 23; ESA: erythropoiesis stimulating agent; ARBs: angiotensin receptor blockers; ACEIs: angiotensin converting enzyme inhibitors; CCBs: calcium channel blockers.
|